| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.09▼ | 3.98▲ | 3.99▲ | 4.06▼ | 4.51▼ |
| MA10 | 4.01▲ | 4.04▲ | 4.06▼ | 3.98▲ | 5.02▼ |
| MA20 | 3.99▲ | 4.09▼ | 4.09▼ | 4.25▼ | 4.65▼ |
| MA50 | 4.07▼ | 4.09▼ | 4.01▲ | 5.03▼ | 3.62▲ |
| MA100 | 4.11▼ | 3.98▲ | 4.02▲ | 4.56▼ | 3.34▲ |
| MA200 | 4.09▼ | 4.35▼ | 4.68▼ | 3.86▲ | 4.53▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.019▲ | -0.017▼ | -0.023▼ | 0.031▲ | -0.214▼ |
| RSI | 52.383▲ | 47.795▼ | 49.459▼ | 43.930▼ | 47.526▼ |
| STOCH | 72.073 | 13.491▼ | 16.307▼ | 65.613 | 25.486 |
| WILL %R | -39.583 | -50.000 | -53.226 | -41.765 | -88.832▼ |
| CCI | 54.667 | 12.531 | -12.952 | 40.156 | -115.936▼ |
|
Thursday, November 20, 2025 12:56 AM
Detailed price information for Inventiva S.A. ADR (IVA-Q) from The Globe and Mail including charting and trades.
|
|
Sunday, November 16, 2025 11:45 PM
November 17, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment ...
|
|
Thursday, November 13, 2025 07:36 AM
November 13, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/11/25 | 4.08 | 4.14 | 4.045 | 4.045 | 11,860 |
| 20/11/25 | 4.09 | 4.20 | 3.88 | 3.88 | 108,595 |
| 19/11/25 | 4.11 | 4.21 | 4.0605 | 4.13 | 186,491 |
| 18/11/25 | 3.99 | 4.23 | 3.99 | 4.18 | 286,496 |
| 17/11/25 | 4.16 | 4.175 | 4.01 | 4.06 | 145,749 |
| 14/11/25 | 3.78 | 4.02 | 3.71 | 4.00 | 226,719 |
| 13/11/25 | 4.00 | 4.07 | 3.55 | 3.82 | 1,310,988 |
| 12/11/25 | 3.82 | 4.10 | 3.8001 | 4.05 | 507,132 |
| 11/11/25 | 3.73 | 3.99 | 3.68 | 3.87 | 1,423,833 |
| 10/11/25 | 3.92 | 3.94 | 3.71 | 3.75 | 203,315 |
|
|
||||
|
|
||||
|
|